Recent years have witnessed remarkable developments in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://phoenixqoau009587.59bloggers.com/39375205/novel-therapeutic-targets-in-diabetes-retatrutide-and-trizepatide